Literature DB >> 2672784

Klebsiella pneumoniae bacteremia in children. Fifty-seven cases in 10 years.

W A Bonadio1.   

Abstract

A review was performed of the 57 cases of Klebsiella pneumoniae bacteremia that occurred in children at our institution during a 10-year period. The rate of K pneumoniae bacteremia relative to all blood cultures in which bacteria were isolated was 1.1%. Children younger than 12 months of age accounted for 38 cases (67%). There were 8 children (14%) who were afebrile at the time bacteremia was documented; other presenting clinical features were generally indistinguishable from those that characterize pediatric bacteremia of more common causes. Fourteen children (25%) were receiving broad-spectrum parenteral antibiotic therapy at the time bacteremia was documented. In 53 patients (93%), an underlying condition predisposing to opportunistic infection was identified, the most common of which were lesions of the gastrointestinal tract (56%), presence of an indwelling central venous catheter (35%), and neutropenia (25%). Klebsiella pneumoniae was a constituent of polymicrobial bacteremia in 15 patients (26%). The overall mortality rate associated with this infection was 20%, with over one half of all deaths occurring in infants who were afebrile at the time bacteremia was documented. Klebsiella pneumoniae bacteremia is a relatively uncommon, serious infection that usually occurs in young children with predisposing underlying conditions, and is associated with a significant mortality rate.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2672784     DOI: 10.1001/archpedi.1989.02150210095025

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  8 in total

1.  Electrophysiological correlates of emotional face processing after mild traumatic brain injury in preschool children.

Authors:  Fabien D'Hondt; Maryse Lassonde; Fanny Thebault-Dagher; Annie Bernier; Jocelyn Gravel; Phetsamone Vannasing; Miriam H Beauchamp
Journal:  Cogn Affect Behav Neurosci       Date:  2017-02       Impact factor: 3.282

2.  Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy.

Authors:  J A Korvick; C S Bryan; B Farber; T R Beam; L Schenfeld; R R Muder; D Weinbaum; R Lumish; D N Gerding; M M Wagener
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

3.  Epidemiology and attack index of gram-negative bacteria causing invasive infection in three special-care neonatal units and risk factors for infection.

Authors:  B Fryklund; K Tullus; L G Burman
Journal:  Infection       Date:  1995 Mar-Apr       Impact factor: 3.553

4.  Development of an enzyme-linked immunosorbent assay method for typing and quantitation of Klebsiella pneumoniae lipopolysaccharide: application to serotype O1.

Authors:  S Albertí; S Hernández-Allés; J Gil; J Reina; J Martínez-Beltrán; S Camprubí; J M Tomás; V J Benedí
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

5.  Intrapartum antibiotic prophylaxis increases the incidence of gram-negative neonatal sepsis.

Authors:  E M Levine; V Ghai; J J Barton; C M Strom
Journal:  Infect Dis Obstet Gynecol       Date:  1999

Review 6.  Nosocomial infections in pediatric intensive care units.

Authors:  R Lodha; U C Natchu; M Nanda; S K Kabra; U Chandra; M Natchu
Journal:  Indian J Pediatr       Date:  2001-11       Impact factor: 1.967

7.  Klebsiella pneumoniae bloodstream infections at a South African children's hospital 2006-2011, a cross-sectional study.

Authors:  Heloise Buys; Rudzani Muloiwa; Colleen Bamford; Brian Eley
Journal:  BMC Infect Dis       Date:  2016-10-17       Impact factor: 3.090

8.  A comparison of blood stream infections with extended spectrum beta-lactamase-producing and non-producing Klebsiella pneumoniae in pediatric patients.

Authors:  Sevgen Tanır Basaranoglu; Yasemin Ozsurekci; Kubra Aykac; Eda Karadag Oncel; Asiye Bıcakcigil; Banu Sancak; Ali Bulent Cengiz; Ates Kara; Mehmet Ceyhan
Journal:  Ital J Pediatr       Date:  2017-09-12       Impact factor: 2.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.